Characterization of Parent-of-Origin Methylation Using the Illumina Infinium Methylationepic Array Platform

Abstract

Our comprehensive list of bona fide-imprinted DMR probes will simplify and facilitate methylation profiling of individuals with imprinting disorders and is applicable to other diseases in which aberrant imprinting has been implicated, such as cancer and fetal growth.